Literature DB >> 9469440

Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.

A Pohl-Koppe1, K E Balashov, A C Steere, E L Logigian, D A Hafler.   

Abstract

A novel population of both IFN-gamma- and IL-10-secreting human T cells that differentiate in the presence of exogenous IL-12 in vitro has recently been described. Whether this T cell population exists in vivo is unknown. Borrelia burgdorferi, the etiologic agent of Lyme disease, can induce a chronic infection in the presence of a vigorous humoral immune response. We established T cell lines specific for B. burgdorferi and tetanus toxoid from subjects with chronic B. burgdorferi infection and healthy controls in limiting dilution experiments and assessed proliferation and cytokine secretion. As expected, higher frequencies of B. burgdorferi-specific precursor T cells were observed in Lyme patients compared with controls. In both groups of subjects, T cell lines specific for B. burgdorferi secreted high amounts of IFN-gamma. However, in patients with Lyme disease, 27% of T cell lines secreted not only IFN-gamma but also IL-10, which was only observed in 0.6% of B. burgdorferi-reactive T cell lines generated from controls and in none of the tetanus toxoid-reactive T cell lines generated from either Lyme patients and controls. Single cell PHA cloning confirmed that both cytokines were secreted from one clonally expanded precursor cell. Whole mononuclear cells from B. burgdorferi-infected individuals, but not from controls, secreted IL-12. Moreover, neutralizing anti-IL-12 mAbs inhibited the generation of the IFN-gamma/IL-10 population. These data demonstrate that this novel population of IL-12-induced IFN-gamma/IL-10-secreting T cells is generated in response to chronic B. burgdorferi infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Diagnosis of Lyme borreliosis by a whole-blood gamma interferon assay for cell-mediated immune responses.

Authors:  V K Sikand; J S Rothel; R M Martin
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Role of adrenomedullin in Lyme disease.

Authors:  Meghan L Marre; Courtney T Darcy; Janeth Yinh; Shizuo Akira; Satoshi Uematsu; Allen C Steere; Linden T Hu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

3.  CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.

Authors:  Rong Fang; Nahed Ismail; Thomas Shelite; David H Walker
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

5.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

Review 6.  Role of endogenous and induced regulatory T cells during infections.

Authors:  Elizabeth Wohlfert; Yasmine Belkaid
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

Review 7.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease.

Authors:  Charles R Brown; Annie Y-C Lai; Steven T Callen; Victoria A Blaho; Jennifer M Hughes; William J Mitchell
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization.

Authors:  Hui Xu; Lip Nyin Liew; I Chun Kuo; Chiung Hui Huang; Denise Li-Meng Goh; Kaw Yan Chua
Journal:  Immunology       Date:  2008-03-18       Impact factor: 7.397

10.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.